CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Description of groups caracteristicsWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)


Name (Synonyms) Correlation

Correlated MeSH Terms (1)


Name (Synonyms) Correlation
D001523 Mental Disorders NIH 0.21

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Caracteristics of the Patients Hospitalized With Unvonluntary Commitment Procedure, in Pandemic and Confinement Context

The actual worldwide context (disease outbreak, confinements instaured in many countries) is a stressful factor for many people. It can have consequences on mental health : separation from loved ones, loss of freedom, uncertainty about infection status, boredom. Patients with mental disorders are especially vulnerable. On march 17th, the french government ordonned a national confinement to slow the progression of the COVID-19 outbreak, for 15 days at first then renewed several times. This situation has led to a reorganization of care as requested on March 22nd, 2020 in the recommendations applicable to the organization of care in psychiatric services : priority to telephone contacts and teleconsultation by multiplying contacts and assessments. By the time the reorganization of care became operational, the most vulnerable patients may have experienced a decompensation of their disease. It is important to know if the COVID-19 outbreak combined with the confinement increased the number of unvoluntary commitment the month after the announce of the confinement. This could help us understand which patients are more vulnerable is this context, and improve our organization (ambulatory and hospitalization care) if this situation occurs again.

NCT04417374 COVID 19 Disease Outbreak Mental Disorders Other: Description of groups caracteristics
MeSH:Mental Disorders

Primary Outcomes

Description: Number of hospitalized patients From March 12th to April 09th

Measure: Number of hospitalized patients

Time: 1 months

Secondary Outcomes

Description: Primary psychiatric diagnostic From March 12th to April 09th

Measure: Cause of hospitalization

Time: 1 months

Other Outcomes

Description: Patients without psychiatric antecedent (number) From March 12th to April 09th

Measure: Lengh of hospitalization

Time: 1 months

Description: Presence of absence of history of treatment interruption leading to the hospitalization From March 12th to April 09th

Measure: Treatment interruption

Time: 1 months

Description: Number of hospitalized patients living alone (opposed to those living with family) From March 12th to April 09th

Measure: Number of hospitalized patients living alone

Time: 1 months

Description: Number of patients using drugs From March 12th to April 09th

Measure: Use of drugs

Time: 1 months


No related HPO nodes (Using clinical trials)